248
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

1-Year Prospective Study of the Relationship of Serial Exhaled Nitric Oxide Level and Asthma Control

ORCID Icon, , , , , , & ORCID Icon show all
Pages 725-734 | Received 13 Apr 2023, Accepted 30 Jun 2023, Published online: 14 Jul 2023

References

  • Riise GC, Toren K, Olin A-C. Subjects in a population study with high levels of FENO have associated eosinophil airway inflammation. ISRN Allergy. 2011;2011:792613. doi:10.5402/2011/792613
  • Silkoff PE, Lent AM, Busacker AA, et al. Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma. J Allergy Clin Immunol. 2005;116:1249–1255.
  • Fleming L, Tsartsali L, Wilson N, Regamey N, Bush A. Longitudinal relationship between sputum eosinophils and exhaled nitric oxide in children with asthma. Am J Respir Crit Care Med. 2013;188:400–402.
  • Maspero J, Adir Y, Al-Ahmad M, et al. Type 2 inflammation in asthma and other airway diseases. ERJ Open Res. 2022;8:56.
  • Ko FW, Wang JKL, Hui DSC, et al. A multi-center study of the prevalence and characteristics of eosinophilic phenotype and high ige levels among Chinese patients with severe asthma. J Asthma Allergy. 2023;16:173–182.
  • Brusselle GG, Koppelman GH. Biologic therapies for severe asthma. N Engl J Med. 2022;386:157–171.
  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2022. Available from: www.ginasthma.org. Accessed May 1, 2023.
  • Dweik RA, Boggs PB, Erzurum SC, et al. American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels for Clinical A. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602–615.
  • British Thoracic Society. British guideline on the management of asthma; 2019. Available from: https://www.sign.ac.uk/media/1773/sign158-updated.pdf. Accessed December 20, 2022.
  • Petsky HL, Cates CJ, Kew KM, Chang AB. Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis. Thorax. 2018;73(12):1110–1119. doi:10.1136/thoraxjnl-2018-211540
  • Sato S, Saito J, Fukuhara A, et al. The clinical role of fractional exhaled nitric oxide in asthma control. Ann Allergy Asthma Immunol. 2017;119:541–547.
  • Khalili B, Boggs PB, Shi R, Bahna SL. Discrepancy between clinical asthma control assessment tools and fractional exhaled nitric oxide. Ann Allergy Asthma Immunol. 2008;101:124–129.
  • Visitsunthorn N, Prottasan P, Jirapongsananuruk O, Maneechotesuwan K. Is fractional exhaled nitric oxide (FeNO) associated with asthma control in children? Asian Pac J Allergy Immunol. 2014;32:218–225.
  • Abe Y, Suzuki M, Kimura H, et al. Annual fractional exhaled nitric oxide measurements and exacerbations in severe asthma. J Asthma Allergy. 2020;13:731–741.
  • Garcia E, Zhang Y, Rappaport EB, et al. Patterns and determinants of exhaled nitric oxide trajectories in schoolchildren over a 7-year period. Eur Respir J. 2020;56:2000011.
  • Ko FW, Leung TF, Wong GW, Chu JH, Sy HY, Hui DS. Determinants of, and reference equation for, exhaled nitric oxide in the Chinese population. Eur Respir J. 2013;42:767–775.
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338.
  • Ip MS, Ko FW, Lau AC, et al. Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization. Chest. 2006;129:384–392.
  • American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912–930.
  • Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59–65.
  • Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14:902–907.
  • Schatz M, Kosinski M, Yarlas AS, Hanlon J, Watson ME, Jhingran P. The minimally important difference of the Asthma Control Test. J Allergy Clin Immunol. 2009;124:719–23 e1.
  • Juniper EF, Bousquet J, Abetz L, Bateman ED, Committee G. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir Med. 2006;100:616–621.
  • Syk J, Malinovschi A, Johansson G, et al. Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial. J Allergy Clin Immunol Pract. 2013;1:639–48 e1–8.
  • Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med. 2007;176:231–237.
  • Malinovschi A, Fonseca JA, Jacinto T, Alving K, Janson C. Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects. J Allergy Clin Immunol. 2013;132:821–7 e1–5.
  • Denlinger LC, Phillips BR, Ramratnam S, et al.; National Heart L, Blood Institute’s Severe Asthma Research Program I. Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations. Am J Respir Crit Care Med. 2017;195:302–313.
  • Soma T, Iemura H, Naito E, et al. Implication of fraction of exhaled nitric oxide and blood eosinophil count in severe asthma. Allergol Int. 2018;67S:S3–S11.
  • Pijnenburg MW, Floor SE, Hop WC, De Jongste JC. Daily ambulatory exhaled nitric oxide measurements in asthma. Pediatr Allergy Immunol. 2006;17:189–193.
  • Massaro AF, Gaston B, Kita D, Fanta C, Stamler JS, Drazen JM. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med. 1995;152:800–803.
  • Jones SL, Kittelson J, Cowan JO, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med. 2001;164:738–743.
  • Michils A, Baldassarre S, Van Muylem A. Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients. Eur Respir J. 2008;31:539–546.
  • Juniper EF, Svensson K, Mork AC, Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005;99:553–558.